International Continence Society consensus on the diagnosis and treatment of nocturia
Introduction Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi method to develop a practical algorithm w...
Gespeichert in:
| Veröffentlicht in: | Neurourology and urodynamics 2019-02, Vol.38 (2), p.478-498 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 498 |
|---|---|
| container_issue | 2 |
| container_start_page | 478 |
| container_title | Neurourology and urodynamics |
| container_volume | 38 |
| creator | Everaert, Karel Hervé, Francois Bosch, Ruud Dmochowski, Roger Drake, Marcus Hashim, Hashim Chapple, Christopher Van Kerrebroeck, Philip Mourad, Sherif Abrams, Paul Wein, Alan |
| description | Introduction
Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi method to develop a practical algorithm with a focus on what steps need to be taken before prescribing desmopressin.
Methods
Evidence comes from existing guidelines (Google, PubMed), International Consultation on Incontinence‐Research Society (ICI‐RS) 2017, prescribing information and a Delphi panel (3 rounds). The International Continence Society initiated this study, the authors represent the ICI‐RS, European Association of Urology, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).
Results
Diagnostic packages: consensus on, history taking for all causalities, intake diary (fluid, food) and bladder diary, not for its duration. Pelvic (women) or rectal (men) examination, prostate‐specific antigen, serum sodium check (SSC), renal function, endocrine screening: when judged necessary. Timing or empty stomach when SSC is not important. Therapeutic packages: the safe candidates for desmopressin can be phenotyped as no polydipsia, heart/kidney failure, severe leg edema or obstructive sleep apnea syndrome. Lifestyle interventions may be useful. Initiating desmopressin: risk management consensus on three clinical pictures.
Follow‐up of desmopressin therapy: there was consensus on SSC day 3 to 7, and at 1 month. Stop therapy if SSC is |
| doi_str_mv | 10.1002/nau.23939 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2183641364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2188979441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4549-875448c6ac9e380a151807fa5575cbaab1308397c2a0481fe4c172f9ad4977463</originalsourceid><addsrcrecordid>eNp10E1LAzEQBuAgitbqwT8gAS96WJtsspvkWIofBdGD9rxM01mNbJO6ySL9965t9SB4GOby8DLzEnLG2TVnLB956K5zYYTZIwNe5CwrlVL7ZMCUEFkuS3VEjmN8Z4xpIc0hORJMKSOUHpDZ1CdsPSQXPDR0EnxyHr1F-hysw7SmNviIPnaRBk_TG9KFg1cfoosU_IKmFiEt0ScaauqDTV3r4IQc1NBEPN3tIZnd3rxM7rOHp7vpZPyQWVlIk2lVSKltCdag0Ax4wTVTNRSFKuwcYM5Ff7FRNgcmNa9RWq7y2sBCGqVkKYbkcpu7asNHhzFVSxctNg14DF2scq5FKXk_Pb34Q99D1z_ebJQ2ysgeDsnVVtk2xNhiXa1at4R2XXFWfXdd9V1Xm657e75L7OZLXPzKn3J7MNqCT9fg-v-k6nE820Z-ASYvh7k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2188979441</pqid></control><display><type>article</type><title>International Continence Society consensus on the diagnosis and treatment of nocturia</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Everaert, Karel ; Hervé, Francois ; Bosch, Ruud ; Dmochowski, Roger ; Drake, Marcus ; Hashim, Hashim ; Chapple, Christopher ; Van Kerrebroeck, Philip ; Mourad, Sherif ; Abrams, Paul ; Wein, Alan</creator><creatorcontrib>Everaert, Karel ; Hervé, Francois ; Bosch, Ruud ; Dmochowski, Roger ; Drake, Marcus ; Hashim, Hashim ; Chapple, Christopher ; Van Kerrebroeck, Philip ; Mourad, Sherif ; Abrams, Paul ; Wein, Alan</creatorcontrib><description>Introduction
Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi method to develop a practical algorithm with a focus on what steps need to be taken before prescribing desmopressin.
Methods
Evidence comes from existing guidelines (Google, PubMed), International Consultation on Incontinence‐Research Society (ICI‐RS) 2017, prescribing information and a Delphi panel (3 rounds). The International Continence Society initiated this study, the authors represent the ICI‐RS, European Association of Urology, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).
Results
Diagnostic packages: consensus on, history taking for all causalities, intake diary (fluid, food) and bladder diary, not for its duration. Pelvic (women) or rectal (men) examination, prostate‐specific antigen, serum sodium check (SSC), renal function, endocrine screening: when judged necessary. Timing or empty stomach when SSC is not important. Therapeutic packages: the safe candidates for desmopressin can be phenotyped as no polydipsia, heart/kidney failure, severe leg edema or obstructive sleep apnea syndrome. Lifestyle interventions may be useful. Initiating desmopressin: risk management consensus on three clinical pictures.
Follow‐up of desmopressin therapy: there was consensus on SSC day 3 to 7, and at 1 month. Stop therapy if SSC is <130 mmol/L regardless of symptoms. Stop if SSC is 130 to 135 mmol/L with symptoms of hyponatremia.
Conclusion
A summary of the nocturia patient pathway across different medical specialists is useful in the visualization and phenotyping of patients for diagnosis and therapy. By summarizing basic knowledge of desmopressin, we aim to ease its initiation and shorten the patient journey for nocturia.</description><identifier>ISSN: 0733-2467</identifier><identifier>EISSN: 1520-6777</identifier><identifier>DOI: 10.1002/nau.23939</identifier><identifier>PMID: 30779378</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Antidiuretic Agents - therapeutic use ; Apnea ; Consensus ; Deamino Arginine Vasopressin - therapeutic use ; Delphi technique ; Desmopressin ; Diagnosis ; Edema ; expert opinion ; Female ; Food intake ; guideline ; Heart diseases ; Humans ; Hyponatremia ; interdisciplinary research ; Life Style ; Male ; Middle Aged ; nocturia ; Nocturia - diagnosis ; Nocturia - physiopathology ; Nocturia - therapy ; nocturnal polyuria ; Patients ; Phenotyping ; Polydipsia ; Prostate ; Rectum ; Renal failure ; Renal function ; Sleep ; Sleep disorders ; Societies ; Sodium ; Stomach ; Urodynamics - physiology</subject><ispartof>Neurourology and urodynamics, 2019-02, Vol.38 (2), p.478-498</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4549-875448c6ac9e380a151807fa5575cbaab1308397c2a0481fe4c172f9ad4977463</citedby><cites>FETCH-LOGICAL-c4549-875448c6ac9e380a151807fa5575cbaab1308397c2a0481fe4c172f9ad4977463</cites><orcidid>0000-0002-9079-251X ; 0000-0002-6230-2552 ; 0000-0003-2467-407X ; 0000-0002-2960-9931</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fnau.23939$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fnau.23939$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30779378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Everaert, Karel</creatorcontrib><creatorcontrib>Hervé, Francois</creatorcontrib><creatorcontrib>Bosch, Ruud</creatorcontrib><creatorcontrib>Dmochowski, Roger</creatorcontrib><creatorcontrib>Drake, Marcus</creatorcontrib><creatorcontrib>Hashim, Hashim</creatorcontrib><creatorcontrib>Chapple, Christopher</creatorcontrib><creatorcontrib>Van Kerrebroeck, Philip</creatorcontrib><creatorcontrib>Mourad, Sherif</creatorcontrib><creatorcontrib>Abrams, Paul</creatorcontrib><creatorcontrib>Wein, Alan</creatorcontrib><title>International Continence Society consensus on the diagnosis and treatment of nocturia</title><title>Neurourology and urodynamics</title><addtitle>Neurourol Urodyn</addtitle><description>Introduction
Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi method to develop a practical algorithm with a focus on what steps need to be taken before prescribing desmopressin.
Methods
Evidence comes from existing guidelines (Google, PubMed), International Consultation on Incontinence‐Research Society (ICI‐RS) 2017, prescribing information and a Delphi panel (3 rounds). The International Continence Society initiated this study, the authors represent the ICI‐RS, European Association of Urology, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).
Results
Diagnostic packages: consensus on, history taking for all causalities, intake diary (fluid, food) and bladder diary, not for its duration. Pelvic (women) or rectal (men) examination, prostate‐specific antigen, serum sodium check (SSC), renal function, endocrine screening: when judged necessary. Timing or empty stomach when SSC is not important. Therapeutic packages: the safe candidates for desmopressin can be phenotyped as no polydipsia, heart/kidney failure, severe leg edema or obstructive sleep apnea syndrome. Lifestyle interventions may be useful. Initiating desmopressin: risk management consensus on three clinical pictures.
Follow‐up of desmopressin therapy: there was consensus on SSC day 3 to 7, and at 1 month. Stop therapy if SSC is <130 mmol/L regardless of symptoms. Stop if SSC is 130 to 135 mmol/L with symptoms of hyponatremia.
Conclusion
A summary of the nocturia patient pathway across different medical specialists is useful in the visualization and phenotyping of patients for diagnosis and therapy. By summarizing basic knowledge of desmopressin, we aim to ease its initiation and shorten the patient journey for nocturia.</description><subject>Adult</subject><subject>Aged</subject><subject>Antidiuretic Agents - therapeutic use</subject><subject>Apnea</subject><subject>Consensus</subject><subject>Deamino Arginine Vasopressin - therapeutic use</subject><subject>Delphi technique</subject><subject>Desmopressin</subject><subject>Diagnosis</subject><subject>Edema</subject><subject>expert opinion</subject><subject>Female</subject><subject>Food intake</subject><subject>guideline</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Hyponatremia</subject><subject>interdisciplinary research</subject><subject>Life Style</subject><subject>Male</subject><subject>Middle Aged</subject><subject>nocturia</subject><subject>Nocturia - diagnosis</subject><subject>Nocturia - physiopathology</subject><subject>Nocturia - therapy</subject><subject>nocturnal polyuria</subject><subject>Patients</subject><subject>Phenotyping</subject><subject>Polydipsia</subject><subject>Prostate</subject><subject>Rectum</subject><subject>Renal failure</subject><subject>Renal function</subject><subject>Sleep</subject><subject>Sleep disorders</subject><subject>Societies</subject><subject>Sodium</subject><subject>Stomach</subject><subject>Urodynamics - physiology</subject><issn>0733-2467</issn><issn>1520-6777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1LAzEQBuAgitbqwT8gAS96WJtsspvkWIofBdGD9rxM01mNbJO6ySL9965t9SB4GOby8DLzEnLG2TVnLB956K5zYYTZIwNe5CwrlVL7ZMCUEFkuS3VEjmN8Z4xpIc0hORJMKSOUHpDZ1CdsPSQXPDR0EnxyHr1F-hysw7SmNviIPnaRBk_TG9KFg1cfoosU_IKmFiEt0ScaauqDTV3r4IQc1NBEPN3tIZnd3rxM7rOHp7vpZPyQWVlIk2lVSKltCdag0Ax4wTVTNRSFKuwcYM5Ff7FRNgcmNa9RWq7y2sBCGqVkKYbkcpu7asNHhzFVSxctNg14DF2scq5FKXk_Pb34Q99D1z_ebJQ2ysgeDsnVVtk2xNhiXa1at4R2XXFWfXdd9V1Xm657e75L7OZLXPzKn3J7MNqCT9fg-v-k6nE820Z-ASYvh7k</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Everaert, Karel</creator><creator>Hervé, Francois</creator><creator>Bosch, Ruud</creator><creator>Dmochowski, Roger</creator><creator>Drake, Marcus</creator><creator>Hashim, Hashim</creator><creator>Chapple, Christopher</creator><creator>Van Kerrebroeck, Philip</creator><creator>Mourad, Sherif</creator><creator>Abrams, Paul</creator><creator>Wein, Alan</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9079-251X</orcidid><orcidid>https://orcid.org/0000-0002-6230-2552</orcidid><orcidid>https://orcid.org/0000-0003-2467-407X</orcidid><orcidid>https://orcid.org/0000-0002-2960-9931</orcidid></search><sort><creationdate>201902</creationdate><title>International Continence Society consensus on the diagnosis and treatment of nocturia</title><author>Everaert, Karel ; Hervé, Francois ; Bosch, Ruud ; Dmochowski, Roger ; Drake, Marcus ; Hashim, Hashim ; Chapple, Christopher ; Van Kerrebroeck, Philip ; Mourad, Sherif ; Abrams, Paul ; Wein, Alan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4549-875448c6ac9e380a151807fa5575cbaab1308397c2a0481fe4c172f9ad4977463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antidiuretic Agents - therapeutic use</topic><topic>Apnea</topic><topic>Consensus</topic><topic>Deamino Arginine Vasopressin - therapeutic use</topic><topic>Delphi technique</topic><topic>Desmopressin</topic><topic>Diagnosis</topic><topic>Edema</topic><topic>expert opinion</topic><topic>Female</topic><topic>Food intake</topic><topic>guideline</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Hyponatremia</topic><topic>interdisciplinary research</topic><topic>Life Style</topic><topic>Male</topic><topic>Middle Aged</topic><topic>nocturia</topic><topic>Nocturia - diagnosis</topic><topic>Nocturia - physiopathology</topic><topic>Nocturia - therapy</topic><topic>nocturnal polyuria</topic><topic>Patients</topic><topic>Phenotyping</topic><topic>Polydipsia</topic><topic>Prostate</topic><topic>Rectum</topic><topic>Renal failure</topic><topic>Renal function</topic><topic>Sleep</topic><topic>Sleep disorders</topic><topic>Societies</topic><topic>Sodium</topic><topic>Stomach</topic><topic>Urodynamics - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Everaert, Karel</creatorcontrib><creatorcontrib>Hervé, Francois</creatorcontrib><creatorcontrib>Bosch, Ruud</creatorcontrib><creatorcontrib>Dmochowski, Roger</creatorcontrib><creatorcontrib>Drake, Marcus</creatorcontrib><creatorcontrib>Hashim, Hashim</creatorcontrib><creatorcontrib>Chapple, Christopher</creatorcontrib><creatorcontrib>Van Kerrebroeck, Philip</creatorcontrib><creatorcontrib>Mourad, Sherif</creatorcontrib><creatorcontrib>Abrams, Paul</creatorcontrib><creatorcontrib>Wein, Alan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Neurourology and urodynamics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Everaert, Karel</au><au>Hervé, Francois</au><au>Bosch, Ruud</au><au>Dmochowski, Roger</au><au>Drake, Marcus</au><au>Hashim, Hashim</au><au>Chapple, Christopher</au><au>Van Kerrebroeck, Philip</au><au>Mourad, Sherif</au><au>Abrams, Paul</au><au>Wein, Alan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>International Continence Society consensus on the diagnosis and treatment of nocturia</atitle><jtitle>Neurourology and urodynamics</jtitle><addtitle>Neurourol Urodyn</addtitle><date>2019-02</date><risdate>2019</risdate><volume>38</volume><issue>2</issue><spage>478</spage><epage>498</epage><pages>478-498</pages><issn>0733-2467</issn><eissn>1520-6777</eissn><abstract>Introduction
Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi method to develop a practical algorithm with a focus on what steps need to be taken before prescribing desmopressin.
Methods
Evidence comes from existing guidelines (Google, PubMed), International Consultation on Incontinence‐Research Society (ICI‐RS) 2017, prescribing information and a Delphi panel (3 rounds). The International Continence Society initiated this study, the authors represent the ICI‐RS, European Association of Urology, and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).
Results
Diagnostic packages: consensus on, history taking for all causalities, intake diary (fluid, food) and bladder diary, not for its duration. Pelvic (women) or rectal (men) examination, prostate‐specific antigen, serum sodium check (SSC), renal function, endocrine screening: when judged necessary. Timing or empty stomach when SSC is not important. Therapeutic packages: the safe candidates for desmopressin can be phenotyped as no polydipsia, heart/kidney failure, severe leg edema or obstructive sleep apnea syndrome. Lifestyle interventions may be useful. Initiating desmopressin: risk management consensus on three clinical pictures.
Follow‐up of desmopressin therapy: there was consensus on SSC day 3 to 7, and at 1 month. Stop therapy if SSC is <130 mmol/L regardless of symptoms. Stop if SSC is 130 to 135 mmol/L with symptoms of hyponatremia.
Conclusion
A summary of the nocturia patient pathway across different medical specialists is useful in the visualization and phenotyping of patients for diagnosis and therapy. By summarizing basic knowledge of desmopressin, we aim to ease its initiation and shorten the patient journey for nocturia.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30779378</pmid><doi>10.1002/nau.23939</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0002-9079-251X</orcidid><orcidid>https://orcid.org/0000-0002-6230-2552</orcidid><orcidid>https://orcid.org/0000-0003-2467-407X</orcidid><orcidid>https://orcid.org/0000-0002-2960-9931</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0733-2467 |
| ispartof | Neurourology and urodynamics, 2019-02, Vol.38 (2), p.478-498 |
| issn | 0733-2467 1520-6777 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2183641364 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Adult Aged Antidiuretic Agents - therapeutic use Apnea Consensus Deamino Arginine Vasopressin - therapeutic use Delphi technique Desmopressin Diagnosis Edema expert opinion Female Food intake guideline Heart diseases Humans Hyponatremia interdisciplinary research Life Style Male Middle Aged nocturia Nocturia - diagnosis Nocturia - physiopathology Nocturia - therapy nocturnal polyuria Patients Phenotyping Polydipsia Prostate Rectum Renal failure Renal function Sleep Sleep disorders Societies Sodium Stomach Urodynamics - physiology |
| title | International Continence Society consensus on the diagnosis and treatment of nocturia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T16%3A29%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=International%20Continence%20Society%20consensus%20on%20the%20diagnosis%20and%20treatment%20of%20nocturia&rft.jtitle=Neurourology%20and%20urodynamics&rft.au=Everaert,%20Karel&rft.date=2019-02&rft.volume=38&rft.issue=2&rft.spage=478&rft.epage=498&rft.pages=478-498&rft.issn=0733-2467&rft.eissn=1520-6777&rft_id=info:doi/10.1002/nau.23939&rft_dat=%3Cproquest_cross%3E2188979441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2188979441&rft_id=info:pmid/30779378&rfr_iscdi=true |